SHARE-BASED COMPENSATION (Narrative) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Jul. 04, 2024 |
May 30, 2023 |
|
| Share-Based Compensation [Line Items] | ||||
| Share-based compensation expenses | $ 5,862 | $ 130 | ||
| Warrants issued (in Shares) | 2,413 | |||
| Fair value of equity compensation granted | $ 5,578 | |||
| Restricted Stock Units (RSUs) [Member] | ||||
| Share-Based Compensation [Line Items] | ||||
| Available for grant shares (in Shares) | 78,650 | |||
| Fair value of equity compensation granted | $ 5,578 | |||
| 2024 Equity Incentive Plan [Member] | ||||
| Share-Based Compensation [Line Items] | ||||
| Available for grant shares (in Shares) | 63,953 | |||
| 2023 Equity Incentive Plan [Member] | ||||
| Share-Based Compensation [Line Items] | ||||
| Ordinary shares exercisable term | 10 years | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|